Key result
The Qanadli CT obstruction index (CTOI) predicted 30-day and 3-month mortality in patients with nonmassive acute pulmonary embolism and no cardiopulmonary disease (P≤0.04).
Why the study?
To investigate the prognostic value of an integrative approach combining clinical variables and the Qanadli CT obstruction index in patients with nonmassive acute pulmonary embolism.
Does the Qanadli CT obstruction index (CTOI) predict 30-day and 3-month mortality in patients with nonmassive acute pulmonary embolism?
Cohort (n=705)
Does the Qanadli CT obstruction index (CTOI) predict 30-day and 3-month mortality in patients with nonmassive acute pulmonary embolism?
p-value: p=≤ .04
The Qanadli CT obstruction index (CTOI) can predict mortality outcomes and aid in risk stratification for patients with nonmassive acute pulmonary embolism without preexisting cardiopulmonary disease.
CTOI may aid mortality risk stratification in nonmassive PE without cardiopulmonary disease; hypothesis-generating and requires prospective validation.
PURPOSE: To investigate the prognostic value of an integrative approach combining clinical variables and the Qanadli CT obstruction index (CTOI) in patients with nonmassive acute pulmonary embolism (PE). MATERIALS AND METHODS: This retrospective study included 705 consecutive patients (mean age, 63 years; range, 18-95 years) with proven PE. Clot burden was quantified using the CTOI, which reflects the ratio of fully or partially obstructed pulmonary arteries to normal arteries. Patients were subdivided into two groups according to the presence (group A) or absence (group B) of preexisting cardiopulmonary disease. Thirty-day and 3-month mortality was evaluated. CTOI thresholds of 20% and 40% were used to stratify patients regarding outcome (low, intermediate, and high risk). The predictive value of CTOI was assessed through logistic regression analysis. RESULTS: ≤ .04). CONCLUSION: CTOI predicted outcome in this cohort of patients with PE and no cardiopulmonary disease, and it may provide a simple single-examination-based approach for risk stratification in this subset of patients.
No takes yet. Share an insight, caveat, or question.
Rotzinger et al. (2020) conducted a cohort in Nonmassive acute pulmonary embolism (n=705). Qanadli CT obstruction index (CTOI) was evaluated on 30-day and 3-month mortality (p=≤ .04). The Qanadli CT obstruction index (CTOI) predicted 30-day and 3-month mortality in patients with nonmassive acute pulmonary embolism and no cardiopulmonary disease (P≤0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: